HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


National Regulators Back European Pholcodine Ban

Executive Summary

By majority vote, the Heads of Medicines Agencies' CMDh has agreed to withdraw the marketing authorizations for all drugs containing pholcodine sold in the EU and European Economic Area countries.

You may also be interested in...

OTC Pholcodine Ban Coming To New Zealand

New Zealand will likely be the next country to ban sales of popular OTC dry cough treatment pholcodine following a safety alert issued by the World Health Organization.

Pholcodine Alert Goes Global As WHO Warns Against Use

The World Health Organization has issued a safety alert warning regulators around the world about the potential dangers of pholcodine use following the withdrawal of the cough treatment in Europe and elsewhere.

Pholcodine OTCs Recalled In UK Following Sales Ban

The UK's Medicines and Healthcare products Regulatory Agency has recalled all OTC medicines containing pholcodine marketed in the country after deciding to ban their sale for safety reasons.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts